China · Research startup
China · Baiming Xinkang Biotechnology (Hangzhou) Co., Ltd. Worgpharma)
Worg Pharmaceuticals is a clinical stage biopharmaceutical company developing new treatments for allergies and other diseases.
Funding reportedLast round: Series C
What company datasets say Baiming Xinkang Biotechnology (Hangzhou) Co., Ltd. Worgpharma) raised
Funding, as reported
Reported in all1.7Bin the source's currency
Rounds3
Last roundSeries C
Last round size27.6M
Last round dateJun 2023
Investors listed10
The company, in detail
What they build
Known for
biotechnology researchb2cb2b
Built with from their website
Microsoft 365Alibaba Cloud
- Sector
- Research
- Industry code
- NAICS 325414, 541714, SIC 2834, 2836
- Region
- Zhe Jiang Sheng
- Full record
- Every detail in the company directory
Research in China
Startups like it
CMAB BiopharmaSuzhou · founded 2017Raised
HaploX BiotechnologyShenzhen Shi · founded 2014Raised
TriArm Therapeuticsfounded 2018Raised
Cure GeneticsSuzhou · founded 2016Raised
BGI GroupShenzhen Shi · founded 1999
Abogen BiosciencesWuxi · founded 2019
Chengdu Qitan Technology Co., Ltd.Beijing · founded 2016- Hangzhou DAC Biotech Co., Ltd.Hangzhou · founded 2012
Is this your company?
Add your raise, your deck and your story, and put Baiming Xinkang Biotechnology (Hangzhou) Co., Ltd. Worgpharma) in front of investors. Or tell us what we have wrong.